The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announces a Biomanufacturing Readiness Levels (BRLs) framework to lay the groundwork for a universal assessment of technology maturity and readiness level for commercial biomanufacturing technology adoption.

The BRL framework, described in the Biotechnology and...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) along with the University of Delaware are pleased to announce $3M in Congressionally-directed funding from the National Institute of Standards and Technology (NIST) for new equipment which will support the advancement of biopharmaceutical manufacturing processes and...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $15.8M in planned project activities through the Institute’s Project Call 5.2 for 14 new projects in technology and workforce development that will help to address key opportunities for innovation in the biopharmaceutical industry...

Manufacturing USA’s program office along with 7 manufacturing innovation institutes attended the Smart Manufacturing eXperience (SMX) in “Steel City,” Pittsburg, PA. With a focus on combating the challenges and opportunities to adopt smart manufacturing technologies faced by small and medium-sized manufacturers (SMMs) and others in the industry...

One year ago, President Biden signed Executive Order 14017 directing an all-of-government approach to assessing vulnerabilities in – and strengthening the resilience of – the United States’ critical supply chains. Within six months of taking office, the Administration completed a comprehensive review of the supply chains for four critical products...